EUVIMEDEUVIMED entdecken
Crossref

Catalpol Inhibits Autophagy to Ameliorate Doxorubicin-Induced Cardiotoxicity via the AKT-mTOR Pathway

Bo Liu, Han Xie, Xiongbing Du, Yuyang Zhou, Jiashun Huang

International Heart Journal · 2023

DOI: 10.1536/ihj.23-062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Heart Journal, 2023. Verfasst von Bo Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Cardiotoxicity. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktCardiotoxicityMiceAnimalsDoxorubicinTOR Serine-Threonine KinasesMyocardiumOxidative StressAutophagySuperoxide DismutaseApoptosisMyocytes, CardiacMammalsIridoid Glucosides

Stichwörter der Autor:innen

Beclin1Heart failureMyocardial injuryOxidative stressTraditional Chinese medicine

Substanzen

Proto-Oncogene Proteins c-aktDoxorubicinTOR Serine-Threonine KinasesSuperoxide DismutasecatalpolIridoid Glucosides

Autor:innen und Institutionen

  • Department of Cardiology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology.

Zitieren

APA

Liu, B., Xie, H., Du, X., Zhou, Y., & Huang, J. (2023). Catalpol Inhibits Autophagy to Ameliorate Doxorubicin-Induced Cardiotoxicity via the AKT-mTOR Pathway. International Heart Journal. https://doi.org/10.1536/ihj.23-062

Vancouver

Liu B, Xie H, Du X, Zhou Y, Huang J. Catalpol Inhibits Autophagy to Ameliorate Doxorubicin-Induced Cardiotoxicity via the AKT-mTOR Pathway. International Heart Journal. 2023. doi:10.1536/ihj.23-062

BibTeX
@article{Liu2023,
  author = {Liu, Bo and Xie, Han and Du, Xiongbing and Zhou, Yuyang and Huang, Jiashun},
  title = {Catalpol Inhibits Autophagy to Ameliorate Doxorubicin-Induced Cardiotoxicity via the AKT-mTOR Pathway},
  journal = {International Heart Journal},
  year = {2023},
  doi = {10.1536/ihj.23-062}
}
Kostenlos starten →